IL6 and central nervous system cancer: In GBM (as detected by IHC), tumor cells themselves and peritumoral immune cells can release IL-6, increasing its circulating levels and suggesting that IL-6 may participate in glioma evolution in autocrine or paracrine ways [62,63].